Is sialic acid an independent risk factor for cardiovascular disease? A 17-year follow-up study in Busselton, Western Australia.

[1]  M. Ture,et al.  Association between serum total and lipid-bound sialic acid concentration and the severity of coronary atherosclerosis. , 2002, The Journal of laboratory and clinical medicine.

[2]  A. J. Bass,et al.  Population‐based linkage of health records in Western Australia: development of a health services research linked database , 1999, Australian and New Zealand journal of public health.

[3]  J. Chambers,et al.  Plasma sialic acid and coronary artery atheromatous load in patients with stable chest pain. , 1999, Atherosclerosis.

[4]  J. Kaski,et al.  Serum sialic acid concentration is not associated with the extent or severity of coronary artery disease in patients with stable angina pectoris. , 1998, American heart journal.

[5]  M. Crook,et al.  Serum total sialic acid, a reputed cardiovascular risk factor, and its relationship to lipids, plasma fasting insulin, blood pressure and body mass index in normal individuals. , 1998, Clinical science.

[6]  T. Ulutin,et al.  The Relationship of Various Factors in the Pathogenesis of Atherosclerosis , 1998 .

[7]  J. Pickup,et al.  Higher Serum Sialic Acid in Women Than in Men With NIDDM: Possible Relevance to Increased Cardiovascular Risk in NIDDM Women , 1997, Diabetes Care.

[8]  A. Folsom,et al.  Association between Serum Sialic Acid Concentration and Carotid Atherosclerosis Measured by B-Mode Ultrasound , 1996 .

[9]  T. Welborn,et al.  Age and secular trends in risk factors for cardiovascular disease in Busselton. , 2010, Australian journal of public health.

[10]  G. Watts,et al.  Serum sialic acid as an indicator of change in coronary artery disease. , 1995, Metabolism: clinical and experimental.

[11]  M W Knuiman,et al.  Mortality trends, 1965 to 1989, in Busselton, the site of repeated health surveys and interventions. , 2010, Australian journal of public health.

[12]  W. Barlow,et al.  Robust variance estimation for the case-cohort design. , 1994, Biometrics.

[13]  M. Crook,et al.  Serum Total Sialic Acid and Lipid-Associated Sialic Acid in Normal Individuals and Patients with Myocardial Infarction, and Their Relationship to Acute Phase Proteins , 1993, Annals of clinical biochemistry.

[14]  L. Råstam,et al.  Serum Sialic Acid Concentration Predicts both Coronary Heart Disease and Stroke Mortality: Multivariate Analysis Including 54385 Men and Women during 20.5 Years Follow-up , 1992 .

[15]  V. Tertov,et al.  Characterization of desialylated low-density lipoproteins which cause intracellular lipid accumulation. , 1992, International journal of tissue reactions.

[16]  S Wacholder,et al.  Selecting an efficient design for assessing exposure-disease relationships in an assembled cohort. , 1991, Biometrics.

[17]  L. Råstam,et al.  Serum sialic acid concentration and cardiovascular mortality. , 1991, BMJ.

[18]  K. Jamrozik,et al.  Trends in risk factors for vascular disease in Australia , 1989, The Medical journal of Australia.

[19]  C. J. Schwartz,et al.  Stimulation of receptor‐mediated low density lipoprotein endocytosis in neuraminidase‐treated cultured bovine aortic endothelial cells , 1988, Journal of cellular physiology.

[20]  U. Shettigar,et al.  Plasma sialidase activity in acute myocardial infarction. , 1987, American heart journal.

[21]  R. L. Prentice,et al.  A case-cohort design for epidemiologic cohort studies and disease prevention trials , 1986 .

[22]  G. Born,et al.  Unusually high concentrations of sialic acids on the surface of vascular endothelia. , 1985, British journal of experimental pathology.

[23]  Roland Schauer,et al.  Sialic acids and their role as biological masks , 1985 .

[24]  J. Stuart,et al.  Haematological stress syndrome in atherosclerosis. , 1981, Journal of clinical pathology.

[25]  T. Welborn,et al.  The prevalence of coronary heart disease and associated factors in an Australian rural community. , 1969, American journal of epidemiology.